Epidemiological study to evaluate adherence to treatment in bipolar disorder: Adherence Study
Study identifier:NIS-NES-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Epidemiological study to evaluate adherence to treatment in bipolar disorder: Adherence Study
Medical condition
Bipolar Disorder
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
300
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Jul 2009
Primary Completion Date: -
Study Completion Date: 01 Oct 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Patients diagnosed with bipolar disorder I or II (DSM-IV) in ambulatory settings | - |
Contacts
Investigators
Principal Investigator
Elisa Gil
AstraZeneca Spain EpidemiologyValue Demonstration Unit
